Ensuring that the legitimate supply chain is secure: The impact of the Falsified Medicines Directive providing a new legal framework for Europe
- At: 2012 FIP Congress in Amsterdam (the Netherlands)
- Type: Presentation
- By: DERECQUE-POIS, Monika (GIRP, Brussels, Belgium)
- Co-author(s): Fitzgerald
The presentation will centre on the Falsified Medicines Directive and its subsequent Delegated Acts Consultation, explaining its potential impact and effects on pharmaceutical wholesalers at European level. The audience will learn about the specific requirements wholesalers would need to fulfil in order to comply with the new regulatory framework,.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.